224 related articles for article (PubMed ID: 26238486)
1. mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells.
Huijts CM; Schneiders FL; Garcia-Vallejo JJ; Verheul HM; de Gruijl TD; van der Vliet HJ
J Immunol; 2015 Sep; 195(5):2038-45. PubMed ID: 26238486
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin combined with TGF-β converts human invariant NKT cells into suppressive Foxp3+ regulatory cells.
Moreira-Teixeira L; Resende M; Devergne O; Herbeuval JP; Hermine O; Schneider E; Dy M; Cordeiro-da-Silva A; Leite-de-Moraes MC
J Immunol; 2012 Jan; 188(2):624-31. PubMed ID: 22156591
[TBL] [Abstract][Full Text] [Related]
3. Comment on "mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells".
Moreira-Teixeira L; Leite-de-Moraes M
J Immunol; 2015 Dec; 195(11):5100-1. PubMed ID: 26589745
[No Abstract] [Full Text] [Related]
4. Response to Comment on "mTOR Inhibition Per Se Induces Nuclear Localization of FOXP3 and Conversion of Invariant NKT (iNKT) Cells into Immunosuppressive Regulatory iNKT Cells".
Huijts CM; de Gruijl TD; van der Vliet HJ
J Immunol; 2015 Dec; 195(11):5101-2. PubMed ID: 26589746
[No Abstract] [Full Text] [Related]
5. Bacterial CD1d-restricted glycolipids induce IL-10 production by human regulatory T cells upon cross-talk with invariant NKT cells.
Venken K; Decruy T; Aspeslagh S; Van Calenbergh S; Lambrecht BN; Elewaut D
J Immunol; 2013 Sep; 191(5):2174-83. PubMed ID: 23898038
[TBL] [Abstract][Full Text] [Related]
6. Invariant NKT cells suppress CD8(+) T-cell-mediated allergic contact dermatitis independently of regulatory CD4(+) T cells.
Goubier A; Vocanson M; Macari C; Poyet G; Herbelin A; Nicolas JF; Dubois B; Kaiserlian D
J Invest Dermatol; 2013 Apr; 133(4):980-7. PubMed ID: 23190881
[TBL] [Abstract][Full Text] [Related]
7. Oscillatory mTOR inhibition and Treg increase in kidney transplantation.
Sabbatini M; Ruggiero G; Palatucci AT; Rubino V; Federico S; Giovazzino A; Apicella L; Santopaolo M; Matarese G; Galgani M; Terrazzano G
Clin Exp Immunol; 2015 Nov; 182(2):230-40. PubMed ID: 26077103
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of canonical NF-κB signaling maintains function and stability of human Treg.
Ziegler LS; Gerner MC; Schmidt RLJ; Trapin D; Steinberger P; Pickl WF; Sillaber C; Egger G; Schwarzinger I; Schmetterer KG
FEBS J; 2021 Jan; 288(2):640-662. PubMed ID: 32386462
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin has suppressive and stimulatory effects on human plasmacytoid dendritic cell functions.
Boor PP; Metselaar HJ; Mancham S; van der Laan LJ; Kwekkeboom J
Clin Exp Immunol; 2013 Dec; 174(3):389-401. PubMed ID: 23968562
[TBL] [Abstract][Full Text] [Related]
10. Immature dendritic cells convert anergic nonregulatory T cells into Foxp3- IL-10+ regulatory T cells by engaging CD28 and CTLA-4.
Pletinckx K; Vaeth M; Schneider T; Beyersdorf N; Hünig T; Berberich-Siebelt F; Lutz MB
Eur J Immunol; 2015 Feb; 45(2):480-91. PubMed ID: 25382658
[TBL] [Abstract][Full Text] [Related]
11. Administration of anti-CD25 mAb leads to impaired α-galactosylceramide-mediated induction of IFN-γ production in a murine model.
Rosalia RA; Štěpánek I; Polláková V; Šímová J; Bieblová J; Indrová M; Moravcová S; Přibylová H; Bontkes HJ; Bubeník J; Sparwasser T; Reiniš M
Immunobiology; 2013 Jun; 218(6):851-9. PubMed ID: 23182710
[TBL] [Abstract][Full Text] [Related]
12. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
[TBL] [Abstract][Full Text] [Related]
13. Identification of regulatory Foxp3+ invariant NKT cells induced by TGF-beta.
Monteiro M; Almeida CF; Caridade M; Ribot JC; Duarte J; Agua-Doce A; Wollenberg I; Silva-Santos B; Graca L
J Immunol; 2010 Aug; 185(4):2157-63. PubMed ID: 20639482
[TBL] [Abstract][Full Text] [Related]
14. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
[TBL] [Abstract][Full Text] [Related]
15. Constitutive nuclear localization of NFAT in Foxp3+ regulatory T cells independent of calcineurin activity.
Li Q; Shakya A; Guo X; Zhang H; Tantin D; Jensen PE; Chen X
J Immunol; 2012 May; 188(9):4268-77. PubMed ID: 22490438
[TBL] [Abstract][Full Text] [Related]
16. Mammalian target of rapamycin complex 2 regulates invariant NKT cell development and function independent of promyelocytic leukemia zinc-finger.
Prevot N; Pyaram K; Bischoff E; Sen JM; Powell JD; Chang CH
J Immunol; 2015 Jan; 194(1):223-30. PubMed ID: 25404366
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-dependent modification of IL-12p70 and IL-23 balance in dendritic cells by ligand activation of Valpha24 invariant NKT cells.
Uemura Y; Liu TY; Narita Y; Suzuki M; Nakatsuka R; Araki T; Matsumoto M; Iwai LK; Hirosawa N; Matsuoka Y; Murakami M; Kimura T; Hase M; Kohno H; Sasaki Y; Ichihara Y; Ishihara O; Kikuchi H; Sakamoto Y; Jiao SC; Senju S; Sonoda Y
J Immunol; 2009 Jul; 183(1):201-8. PubMed ID: 19542431
[TBL] [Abstract][Full Text] [Related]
19. Synergy between rapamycin and FLT3 ligand enhances plasmacytoid dendritic cell-dependent induction of CD4+CD25+FoxP3+ Treg.
Biswas M; Sarkar D; Kumar SR; Nayak S; Rogers GL; Markusic DM; Liao G; Terhorst C; Herzog RW
Blood; 2015 May; 125(19):2937-47. PubMed ID: 25833958
[TBL] [Abstract][Full Text] [Related]
20. Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells.
Gallon L; Traitanon O; Yu Y; Shi B; Leventhal JR; Miller J; Mas V; L X; Mathew JM
Transplantation; 2015 Sep; 99(9):1774-84. PubMed ID: 25905982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
